Search results for "0.9"

showing 10 items of 2547 documents

Thrombosis and thromboembolism related to COVID‐19: A clarion call for obtaining solid estimates from large‐scale multicenter data

2020

Abstract The clinical spectrum of coronavirus disease 2019 (COVID‐19) is wide, ranging from minor, nonspecific symptoms to severe pneumonia, acute respiratory distress syndrome, multiorgan involvement, and shock. In severe cases, the acute systemic inflammatory response, coagulation activation, and diffuse endothelial damage may, in combination with hypoxia, immobilization, and underlying risk factors, result in potentially life‐threatening venous and arterial thrombotic events. The first data from single‐center retrospective studies suggest that thrombotic events are a key aspect of COVID‐19‐associated morbidity and mortality. We have planned and will be launching the COvid REgistry on THR…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Hospitalized patientsvenous thromboembolism610 Medicine & healthAcute respiratory distressregistrymedicine.disease_causeSARS‐CoV‐2COVID‐19Internal medicineMedicineIn patientthrombosisCoronavirusCOVIDbusiness.industryForumlcsh:RC633-647.510031 Clinic for AngiologyRetrospective cohort studyHematologylcsh:Diseases of the blood and blood-forming organsHypoxia (medical)medicine.diseaseThrombosismedicine.symptombusinessResearch and Practice in Thrombosis and Haemostasis
researchProduct

COVID-19 Vaccine: A Survey of Hesitancy in Patients with Celiac Disease

2021

(1) Background: COVID-19 vaccination campaigns offer the best hope of controlling the pandemic. However, the fast production of COVID-19 vaccines has caused concern among the general public regarding their safety and efficacy. In particular, patients with chronic illnesses, such as celiac disease (CD), may be more fearful. Information on vaccine hesitancy plays a pivotal role in the development of an efficient vaccination campaign. In our study, we aimed to evaluate COVID-19 vaccine hesitancy among Italian CD patients. (2) Methods: an anonymous questionnaire was sent to CD patients followed at our tertiary referral center for CD in Milan, Italy. Patients were defined as willing, hesitant an…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)ImmunologyCOVID-19 vaccinesDiseaseArticle03 medical and health sciences0302 clinical medicineInternal medicineDrug DiscoveryPandemicMedicinePharmacology (medical)Adverse effectPharmacologyResponse rate (survey)business.industryRCOVID-19Odds ratiovaccinesConfidence intervalVaccinationInfectious Diseases030220 oncology & carcinogenesisMedicinevaccine hesitancy030211 gastroenterology & hepatologybusinessCOVID-19 vaccineceliac diseaseVaccines
researchProduct

Impact of daytime routine modifications on people with severe intellectual disability amid COVID‐19 pandemic

2021

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)PandemicIntellectual disabilitymedicineGeneral MedicinePshychiatric Mental HealthPsychologymedicine.diseasePsychiatryPerspectives in Psychiatric Care
researchProduct

COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNI…

2020

International audience; Introduction - Patients treated for malignancy are considered at risk of severe COVID-19. This exceptional pandemic has affected countries on every level, particularly health systems which are experiencing saturation. Like many countries, France is currently greatly exposed, and a complete reorganization of hospitals is ongoing. We propose here adaptations of diagnostic procedures, therapies and care strategies for patients treated for digestive cancer during the COVID-19 epidemic. Methods - French societies of gastroenterology and gastrointestinal (GI) oncology carried out this study to answer two main questions that have arisen (i) how can we limit high-risk situat…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Pneumonia ViralDigestive cancerMEDLINEAntineoplastic AgentsFrench Clinical Practice Guidelines[SDV.CAN]Life Sciences [q-bio]/CancerComorbidityMalignancyBetacoronavirus03 medical and health sciences0302 clinical medicineHealth carePandemicDisease Transmission InfectiousHumansChemotherapyMedicineInfection controlIntensive care medicinePandemicsDigestive System Surgical ProceduresSocieties MedicalGastrointestinal NeoplasmsInfection ControlHepatologySARS-CoV-2business.industryGastroenterologyCOVID-19Evidence-based medicinemedicine.diseaseComorbidityPatient Care ManagementCOVID-19 infection3. Good health030220 oncology & carcinogenesisSurgery030211 gastroenterology & hepatologyFranceCoronavirus InfectionsbusinessDigestive and Liver Disease
researchProduct

Recommendations of the Thoracic Imaging Section of the German Radiological Society for clinical application of chest imaging and structured CT report…

2020

This information provided by the Thoracic Imaging Section of the German Radiological Society is intended to give physicians recommendations on the use of thoracic imaging procedures in the context of the current COVID-19 pandemic. It represents the consensus of the authors based on the previous scientific knowledge and is intended to provide guidance for unified, structured CT reporting if COVID-19 pneumonia is suspected. The recommendations presented correspond to state of knowledge at the time of print and will be updated according to the results of ongoing and future scientific studies. KEY POINTS:: · COVID-19. · chest imaging. · German Radiological Society. CITATION FORMAT: · Vogel-Clau…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Pneumonia ViralMEDLINEContext (language use)030218 nuclear medicine & medical imagingGerman03 medical and health sciences0302 clinical medicineGermanyPandemicMedicineHumansRadiology Nuclear Medicine and imagingMedical physicsPandemicsbusiness.industryCOVID-19language.human_languageSection (archaeology)Radiology Nuclear Medicine and imagingRadiological weaponlanguage030211 gastroenterology & hepatologyRadiography ThoracicbusinessCitationCoronavirus InfectionsRadiologySocietiesTomography X-Ray ComputedRoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin
researchProduct

Epidemiological Measures in the Context of the COVID-19 Pandemic.

2020

BACKGROUND: The various epidemiological indicators used to communicate the impact of COVID-19 have different strengths and limitations. METHODS: We conducted a selective literature review to identify the indicators used and to derive appropriate definitions. We calculated crude and age-adjusted indicators for selected countries. RESULTS: The proportion of deaths (case fatality proportion [CFP]; number of deaths/total number of cases) is commonly used to estimate the severity of a disease. If the CFP is used for purposes of comparison, the existence of heterogeneity in the detection and registration of cases and deaths has to be taken into account. In the early phase of an epidemic, when cas…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)PopulationPneumonia ViralContext (language use)Review ArticleDisease030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineEpidemiologyPandemicCase fatality ratemedicineHumans030212 general & internal medicineeducationLetters to the EditorPandemicseducation.field_of_studybusiness.industryOutbreakCOVID-19General MedicinebusinessCoronavirus InfectionsDemographyDeutsches Arzteblatt international
researchProduct

Recomendaciones prácticas para el manejo del paciente con dolor crónico durante la pandemia de COVID-19

2021

Resumen La infeccion por SARS-CoV-2 ha evolucionado hasta convertirse progresivamente en una pandemia y en una emergencia de salud publica de importancia internacional que ha obligado a las organizaciones de salud a nivel mundial, regional y local a adoptar una serie de medidas para hacer frente a la COVID-19 e intentar disminuir su impacto, no solo en el ambito social sino tambien en el ambito sanitario, modificandose las pautas de actuacion en los servicios de salud. Dentro de estas recomendaciones, que incluyen las unidades de tratamiento del dolor, los pacientes con sospecha o infeccion confirmada por SARS-CoV-2 pueden encontrase en situacion de espera para consulta medica o tecnicas in…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Critical Care and Intensive Care MedicineArticleHealth servicesHealth personnelSpecial Article03 medical and health sciences0302 clinical medicinePandemicHumansPain ManagementMedicine030212 general & internal medicineOpioidesPandemicsSARS-CoV-2business.industryRisk of infectionPublic healthChronic painManejo del dolorCOVID-19General Medicinemedicine.diseaseDolor crónicoOpioidsAnesthesiology and Pain MedicineEsteroidesSteroidsMedical emergencyChronic PainbusinessHumanities030217 neurology & neurosurgeryRevista Española de Anestesiología y Reanimación
researchProduct

Why Does COVID-19 Case Fatality Rate Vary Among Countries?

2020

SummaryBackgroundWhile the epidemic of SARS-CoV-2 is spreading worldwide, there is much concern over the mortality rate that the infection induces. Available data suggest that COVID-19 case fatality rate varies temporally (as the epidemic progresses) and spatially (among countries). Here, we attempted to identify key factors possibly explaining the variability in case fatality rate across countries.MethodsWe used data on the temporal trajectory of case fatality rate provided by the European Center for Disease Prevention and Control, and country-specific data on different metrics describing the incidence of known comorbidity factors associated with an increased risk of COVID-19 mortality at …

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)[SDV]Life Sciences [q-bio]Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Public healthIncidence (epidemiology)Mortality rate010102 general mathematics030204 cardiovascular system & hematologymedicine.disease01 natural sciencesComorbidity3. Good health03 medical and health sciencesCountry level0302 clinical medicineGeographyIncreased riskCase fatality ratemedicineDisease prevention030212 general & internal medicine0101 mathematicsDemographySSRN Electronic Journal
researchProduct

COVID-19: Relationship and Impact on Breastfeeding-A Systematic Review.

2021

COVID-19 is an infectious disease caused by the SARS-CoV-2 virus that was declared a Public Health Emergency of International Concern by the World Health Organization (WHO). One major problem faced is whether breastfeeding by mothers infected with the virus is safe. The objective of this work is to study the impact that the SARS-CoV-2 virus can have on breastfeeding, and whether the virus or antibodies can be transmitted from mother to child through milk. We carried out a systematic review of studies focusing on the impact of SARS-CoV-2 on breastfeeding by mothers infected with the virus. The bibliographic search was done through Medline (Pubmed), MedlinePlus and Google Scholar. From 292 re…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)breastfeedingvirusesBreastfeedingMEDLINEbreastmilkReviewMedlinePlusPregnancyvaccineMedicineHumansTX341-641Pregnancy Complications Infectiousinternet.websiteinternetPregnancyNutrition and DieteticsMilk HumanNutrition. Foods and food supplybusiness.industrySARS-CoV-2Public healthfungiCOVID-19Infantmedicine.diseaseInfectious Disease Transmission Verticalimmune systemBreast FeedingInfectious disease (medical specialty)Family medicineFemalebusinessBreast feedingFood ScienceNutrients
researchProduct

Hospital Admissions for Acute Myocardial Infarction Before and After Lockdown According to Regional Prevalence of COVID-19 and Patient Profile

2020

Aim: to evaluate the impact of a nationwide lockdown in France on acute myocardial infarction (AMI) admissions, by patient characteristics and regional prevalence of the pandemic. Methods and Results: We collected data from 21 centres participating in the on-going FRENCHIE registry (NCT04050956), which collects data from all patients admitted for STEMI or NSTEMI within 48 hours of symptom onset. We compared weekly admissions in the 4 weeks preceding and the 4 weeks following institution of the lockdown. We observed a brutal 30% decrease in AMI admissions (24% for STEMI and 36% for NSTEMI, P=0.14) following institution of the lockdown, with similar trends according to gender (30% decrease in…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)business.industryFamily medicineHospital admissionmedicinePatient profilePatient characteristicsIn patientSymptom onsetbusinessRegulatory authoritySSRN Electronic Journal
researchProduct